| Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 12.05B | 12.06B | 11.41B | 10.79B | 11.34B | 10.39B |
| Gross Profit | 6.34B | 6.46B | 6.02B | 5.43B | 5.85B | 5.05B |
| EBITDA | 8.63B | 8.63B | 8.08B | 7.55B | 7.96B | 7.13B |
| Net Income | 3.17B | 3.11B | 3.16B | 2.95B | 2.93B | 2.73B |
Balance Sheet | ||||||
| Total Assets | 118.63B | 118.50B | 118.54B | 121.00B | 114.83B | 111.57B |
| Cash, Cash Equivalents and Short-Term Investments | 45.00M | 30.00M | 21.00M | 325.00M | 34.00M | 52.00M |
| Total Debt | 51.39B | 50.86B | 50.21B | 51.21B | 46.63B | 44.89B |
| Total Liabilities | 70.11B | 69.21B | 69.56B | 71.67B | 66.44B | 63.82B |
| Stockholders Equity | 48.51B | 49.29B | 48.98B | 49.33B | 48.39B | 47.74B |
Cash Flow | ||||||
| Free Cash Flow | 2.31B | 2.38B | 3.79B | -993.00M | 1.36B | 1.13B |
| Operating Cash Flow | 5.88B | 6.38B | 8.07B | 4.77B | 6.19B | 5.94B |
| Investing Cash Flow | -3.55B | -3.99B | -4.38B | -6.08B | -5.03B | -5.05B |
| Financing Cash Flow | -2.34B | -2.38B | -4.04B | 1.61B | -1.19B | -1.10B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
73 Outperform | HK$93.14B | 7.14 | 13.23% | 5.89% | 1.42% | -10.32% | |
71 Outperform | HK$179.25B | 15.89 | 10.96% | 4.54% | 2.02% | 51.27% | |
69 Neutral | HK$57.35B | 18.17 | 6.56% | 5.08% | 2.58% | 1.42% | |
66 Neutral | $17.65B | 18.10 | 5.60% | 3.62% | 6.62% | 11.55% | |
65 Neutral | HK$133.04B | 23.64 | 9.86% | 4.94% | 0.36% | 2.55% | |
63 Neutral | HK$117.79B | 9.31 | 8.00% | 4.74% | -3.78% | 34.93% | |
62 Neutral | HK$121.90B | 19.49 | 7.05% | 5.15% | -24.63% | 1.74% |